Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis

British Journal of Ophthalmology

Volumn 92, Issue 9, 2008, Pages 1201-1205

  Goldblum, D ^a,b   Bachmann, C ^a   Tappeiner, C ^a   Garweg, J ^c   Frueh, B E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c Swiss Eye Institute   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; VALACICLOVIR;

ADULT; ARTICLE; CELL LOSS; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; CORNEA THICKNESS; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; HEADACHE; HERPES SIMPLEX KERATITIS; HUMAN; KAPLAN MEIER METHOD; MALE; NAUSEA; PENETRATING KERATOPLASTY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT DISEASE; TREATMENT RESPONSE; VISUAL ACUITY;

ACYCLOVIR; ADMINISTRATION, ORAL; AGED; ANTIVIRAL AGENTS; CORNEAL OPACITY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GRAFT REJECTION; HUMANS; KERATITIS, HERPETIC; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VALINE; VISUAL ACUITY;

EID: 51149085405     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2008.138065     Document Type: Article

References (22)

1. Weller S, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993;54:595-605.
2. Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995;39:1546- 53.
3. Beutner KR. Valacyclovir: a review of Its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995;28:281-90.
4. Miserocchi E, Modorati G, Galli L, et al. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol 2007;144:547-51.
5. Holladay JT. Visual acuity measurements. J Cataract Refract Surg 2004;30:287-90.
6. Frueh B, Böhnke M. Prospective, randomized clinical evaluation of optisol vs organ culture corneai storage media. Arch Ophthalmol 2000;118:757-60.
7. Nicholls SM, Shimeld C, Easty DL, et al. Recurrent herpes simplex after corneal transplantation in rats. Invest Ophthalmol Vis Sci 1996;37:425-35.
8. Polcicova K, Biswas PS, Banerjee K, et al. Herpes keratitis In the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci USA 2005;102:11462-7.
9. Ohara PT, Chin MS, LaVail JH. The spread of herpes simplex virus type 1 from trigeminal neurons to the murine cornea: an immunoelectron microscopy study. J Virol 2000;74:4776-86.
10. Barron BA, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 1994;101:1871-82.
11. Herpetic Eye Disease Study Group. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N Engl J Med 1998;339:300-6.
12. Herpetic Eye Disease Study Group. Oral acyclovir for herpes simplex virus eye disease: effect on prevention of epithelial keratitis and stromal keratitis. Arch Ophthalmol 2000;118:1030-6.
13. Foster CS, Barney NP. Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis. Doc Ophthalmol 1992;80:363-9.
14. Barney NP, Foster CS. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 1994;13:232-6.
15. Akova YA, Onat M, Duman S. Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex heratitis. Ocul Immunol Inflamm 1999;7:51-60.
16. Tambasco FP, Cohen EJ, Nguyen LH, et al. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Arch Ophthalmol 1999;117:445-9.
17. van Rooij J, Rijneveld WJ, Remeijer L, et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology 2003;110:1916- 19.
18. Miserocchi E, Modorati G, Galli L, et al. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol 2007;144:547-51.
19. Dias C, Nashed Y, Atluri H, et al. Ocular penetration of acyclovir and its peptide prodrugs valacyclovir and val-valacyclovir following systemic administration in rabbits: an evaluation using ocular microdialysis and LC-MS. Curr Eye Res 2002;25:243-52.
20. Harding SP, Rigal D, Sharma MS, et al. Superior intraocular penetration of aciclovir after valaciclovir in comparison with oral aciclovir. ICAAC; 24-27 September 1998, San Diego, CA, 1998.
21. Huynh TH, Johnson MW, Comer GM, et al. Vitreous penetration of orally administered valacylovir. Invest Ophthalmol Vis Sci 2007;48:76.
22. Lairson DR, Begley CE, Reynolds TF, Wilhelmus KR. Prevention of herpes simplex virus eye disease: a cost-effectiveness analysis. Arch Ophthalmol 2003;121:108-12.